G01N 2333/96447
Factor vii
Official title: Factor VII (3.4.21.21)
G01N2333/96447 (Factor vii) appears on 38 US grants and 49 published applications in this corpus.
Search patents in G01N- Granted patents
- 38
- Published applications
- 49
- Assignees
- 44
- Inventors
- 101
- Latest grant
- 31 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 5 |
| 2003 | 2 | 8 |
| 2004 | 1 | 1 |
| 2005 | 1 | 2 |
| 2006 | 1 | 1 |
| 2007 | 0 | 2 |
| 2008 | 0 | 2 |
| 2009 | 1 | 2 |
| 2010 | 1 | 1 |
| 2011 | 3 | 4 |
| 2012 | 0 | 2 |
| 2013 | 1 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 1 |
| 2016 | 0 | 3 |
| 2017 | 2 | 3 |
| 2018 | 0 | 2 |
| 2019 | 2 | 2 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure31 Mar 2026US 12,590,975 B2Biomerieux
- TFPI inhibitors and methods of use24 Oct 2023US 11,793,855 B2Takeda Pharmaceutical Company Limited
- Methods and compositions for diagnosis and prognosis of renal injury and renal failure27 Sep 2022US 11,454,635 B2Astute Medical, Inc.
- TFPI inhibitors and methods of use12 Feb 2019US 10,201,586 B2Baxalta Incorporated
- Biomarkers associated with schizophrenia5 Feb 2019US 10,197,580 B2Cambridge Enterprises Limited
- Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure22 Jun 2023US 2023/0194552 A1Astute Medical, Inc.
- Screening method for selected amino-lipid-containing compositions10 Mar 2022US 2022/0074925 A1Arbutus Biopharma Corporation
- Biomarkers for predicting degree of weight loss3 Sep 2020US 2020/0278352 A1Societe des Produits Nestle S. A.
- Screening method for selected amino-lipid-containing compositions16 Jul 2020US 2020/0225215 A1Arbutus Biopharma Corporation
- Biomarkers for predicting degree of weight loss29 Aug 2019US 2019/0265248 A1Nestec S. A.
Most cited
By later US patents
- Fluidic device for medical diagnostics220US 6,521,182 B1LifeScan, Inc. · 2003
- Initiation of an analytical measurement in blood180US 6,084,660 ALifeScan, Inc. · 2000
- Microdroplet dispensing for a medical diagnostic device157US 6,830,934 B1LifeScan, Inc. · 2004
- Fluidic device for medical diagnostics125US 7,022,286 B2LifeScan, Inc. · 2006
- Treatment of bleeding with modified tissue factor in combination with an activator of FVII62US 5,504,064 AOklahoma Medical Research Foundation · 1996